First Trust NYSE Arca Biotechnology Index Fund
107 hedge funds and large institutions have $274M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 47 reducing their positions, and 14 closing their positions.
426% more call options, than puts
Call options by funds: $1.41M | Put options by funds: $269K
0% more funds holding
Funds holding: 107 → 107 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
0.25% less ownership
Funds ownership: 34.06% → 33.81% (-0.25%)
8% less capital invested
Capital invested by funds: $297M → $274M (-$22.9M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
45% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$5.8M |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$1.37M |
| 3 |
MWM
MinichMacGregor Wealth Management
Saratoga Springs,
New York
|
+$1.24M |
| 4 |
Morgan Stanley
New York
|
+$1.06M |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$856K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$14.9M |
| 2 |
Jane Street
New York
|
-$7.02M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6.61M |
| 4 |
VF
Virtu Financial
New York
|
-$2.54M |
| 5 |
AIG
American International Group
New York
|
-$2.4M |
FBT Hedge Fund Activity: Q2 2016 in Review
107 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2016, worth a combined $274M — down 7.7% from $297M a quarter earlier.
Fund positioning in FBT was balanced in Q2 2016: 14 funds opened new positions, 14 closed out, 26 added to existing stakes and 47 trimmed.
The largest buyer was SG Americas Securities, adding an estimated $5.8M. The largest seller was LPL Financial, cutting an estimated $14.9M.
- 107 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $274M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2016, down 7.7% quarter-over-quarter.
- 14 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2016 and 14 closed out, a net change of 0 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2016 was SG Americas Securities, an estimated $5.8M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2016 was LPL Financial, an estimated $14.9M sold.
Based on aggregated 13F filings for Q2 2016.